About Us

Protalix Biotherapeutics (NY: PLX )

1.220 -0.080 (-6.15%)
Official Closing Price Updated: 8:00 PM EST, Nov 6, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
September 21, 2008
Form 8-K
Source: SEC/Edgar
September 07, 2008
Form 8-K
Source: SEC/Edgar
July 31, 2008
Form SC 13D
Source: SEC/Edgar
July 28, 2008
Form 8-K
Source: SEC/Edgar
July 14, 2008
Form 8-K
Source: SEC/Edgar
June 30, 2008
Form 8-K
Source: SEC/Edgar
June 02, 2008
Form 8-K
Source: SEC/Edgar
May 11, 2008
Form 8-K
Source: SEC/Edgar
April 08, 2008
Form 8-K
Source: SEC/Edgar
February 12, 2008
Form S-8
Source: SEC/Edgar
January 31, 2008
Form 8-K
Source: SEC/Edgar
January 21, 2008
Form 8-K
Source: SEC/Edgar
January 16, 2008
Form DEF 14A
Source: SEC/Edgar
December 30, 2007
Form 8-K
Source: SEC/Edgar
December 04, 2007
Form 8-K
Source: SEC/Edgar
December 02, 2007
Form 8-K
Source: SEC/Edgar
November 28, 2007
Form 8-K
Source: SEC/Edgar
November 01, 2007
Form 8-K
Source: SEC/Edgar
October 24, 2007
Form S-3MEF
Source: SEC/Edgar
October 24, 2007
Form 8-K
Source: SEC/Edgar
October 24, 2007
Form 424B5
Source: SEC/Edgar
October 24, 2007
Form 8-K
Source: SEC/Edgar
October 08, 2007
Form 424B5
Source: SEC/Edgar
October 04, 2007
Form EFFECT
Source: SEC/Edgar
September 25, 2007
Form S-3/A
Source: SEC/Edgar
September 23, 2007
Form S-3/A
Source: SEC/Edgar
September 23, 2007
Form 8-K/A
Source: SEC/Edgar
September 19, 2007
Form 8-K
Source: SEC/Edgar
September 18, 2007
Form 8-K
Source: SEC/Edgar
August 26, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.